Raphael Isaacs

979 total citations
3 papers, 45 citations indexed

About

Raphael Isaacs is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Raphael Isaacs has authored 3 papers receiving a total of 45 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hematology, 1 paper in Genetics and 1 paper in Pediatrics, Perinatology and Child Health. Recurrent topics in Raphael Isaacs's work include Hemoglobinopathies and Related Disorders (1 paper), Erythrocyte Function and Pathophysiology (1 paper) and Blood groups and transfusion (1 paper). Raphael Isaacs is often cited by papers focused on Hemoglobinopathies and Related Disorders (1 paper), Erythrocyte Function and Pathophysiology (1 paper) and Blood groups and transfusion (1 paper). Raphael Isaacs collaborates with scholars based in . Raphael Isaacs's co-authors include and has published in prestigious journals such as JAMA and Journal of the American Medical Association.

In The Last Decade

Raphael Isaacs

3 papers receiving 36 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raphael Isaacs 3 23 20 13 11 11 3 45
H. Harold Scott Sweden 3 10 0.4× 4 0.2× 17 1.3× 13 1.2× 7 0.6× 3 40
James McBurney Canada 2 19 0.8× 9 0.5× 2 0.2× 12 1.1× 5 0.5× 2 38
M. Živković United States 3 10 0.4× 3 0.1× 15 1.2× 3 0.3× 12 1.1× 6 62
Dominiek Mazure Belgium 4 30 1.3× 8 0.4× 14 1.1× 3 0.3× 15 1.4× 9 51
R. Baggio France 4 14 0.6× 6 0.3× 11 0.8× 3 0.3× 2 0.2× 7 35
P.R.S. Wright United Kingdom 3 19 0.8× 2 0.1× 5 0.4× 2 0.2× 5 0.5× 6 43
Sadia Noorani United Kingdom 1 20 0.9× 22 1.1× 31 2.4× 3 0.3× 12 1.1× 2 41
Pietro Fabris Italy 5 52 2.3× 16 0.8× 4 0.3× 8 0.7× 6 67
Maurizio Cantini Italy 3 21 0.9× 19 0.9× 5 0.4× 5 0.5× 2 0.2× 9 34
A. Prezotti Brazil 4 32 1.4× 11 0.6× 5 0.4× 28 2.5× 3 0.3× 9 65

Countries citing papers authored by Raphael Isaacs

Since Specialization
Citations

This map shows the geographic impact of Raphael Isaacs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Isaacs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Isaacs more than expected).

Fields of papers citing papers by Raphael Isaacs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Isaacs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Isaacs. The network helps show where Raphael Isaacs may publish in the future.

No nodes

All Works

3 of 3 papers shown
1.
Isaacs, Raphael. (1962). The haemolytic anaemias, congenital and acquired. Part II: The auto-immune haemolytic anaemias. JAMA. 182(11). 25 indexed citations
2.
Isaacs, Raphael. (1960). Hemophilia and Other Hemorrhagic States: International Symposium, Rome. Journal of the American Medical Association. 173(3). 321–321. 2 indexed citations
3.
Isaacs, Raphael. (1954). TREATMENT OF POLYCYTHEMIA VERA WITH DARAPRIM. Journal of the American Medical Association. 156(16). 1491–1491. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026